Viewing StudyNCT03298061



Ignite Creation Date: 2024-05-06 @ 10:35 AM
Last Modification Date: 2024-10-26 @ 12:32 PM
Study NCT ID: NCT03298061
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2017-09-27

Brief Title: Long-term Access Program LAP of Mepolizumab for Subjects Who Participated in Study MEA115921
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04-14
Start Date Type: ACTUAL
Primary Completion Date: 2023-02-16
Primary Completion Date Type: ACTUAL
Completion Date: 2023-02-16
Completion Date Type: ACTUAL
First Submit Date: 2017-09-27
First Submit QC Date: September 27 2017
Study First Post Date: 2017-09-29
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2024-03-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-14
Last Update Post Date: 2024-03-12
Last Update Post Date Type: ACTUAL